Accuronix Therapeutics

Accuronix Therapeutics Overview

Founded 2015
Founded
Status Private
Latest Deal Type Early Stage VC
Latest Deal Amount $625K
Latest Deal Amount
Investors 2

Accuronix Therapeutics General Information

Description

Developer of novel therapies designed to solve the most difficult problems in cancer therapy. The company's therapies are based on technology that selectively targets Sigma-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 20 South Sarah Street
  • Saint Louis, MO 63108
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuronix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 28-Jan-2016 $625K 00000 Completed Startup
1. Early Stage VC 0000 0000 Completed Startup

Accuronix Therapeutics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
ImmunityBio Angel-Backed Culver City, CA 00000 000000000000 00000
0000000 0000000000 Venture Capital-Backed Bozeman, MT 0 000.00 0000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Schlieren, Switzerland 000.00 0000000000 0 000.00

Accuronix Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Dennis Schafer Chief Executive Officer & President
Linda Law Vice President, Clinical Development & Chief Medical Officer
Robert Mach Ph.D Co-Founder
William Hawkins MD Co-Founder

Accuronix Therapeutics Board Members (1)

Name Representing Role Since
Charles Bolten BioGenerator Board Member 000 0000

Accuronix Therapeutics Investors (2)

To view Accuronix Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioGenerator Venture Capital Minority 000 0000 000000 0
Missouri Technology Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial